Amicus Therapeutics (FOLD) Jumps: Stock Up 20.7% - Tale of the Tape

By Zacks Equity Research,

Shutterstock photo

Amicus Therapeutics, Inc. ( FOLD ) was a big mover last session, as its shares rose nearly 21% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend for the company since Apr 10, as the stock is now trading above the volatile price range of $1.82 to $2.15.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Amicus Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Better-ranked stocks in the medical sector include TrovaGene, Inc. ( TROV ), ZIOPHARM Oncology, Inc. ( ZIOP ) and Regeneron Pharmaceuticals, Inc. ( REGN ). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

AMICUS THERAPT (FOLD): Free Stock Analysis Report

REGENERON PHARM (REGN): Free Stock Analysis Report


ZIOPHARM ONCLGY (ZIOP): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: FOLD , REGN , TROV , ZIOP

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by